Understandably, clinical guidelines can’t always be immediately translated to the frontline, said Nisa Maruthur, MD, MHS, speaking with Patient Care® about the new American Diabetes Association/European Association for the Study of Diabetes (ADA/EASD) consensus report on the treatment of type 2 diabetes.
Maruthur, a primary care physician focused on T2D clinical care and research, understands the challenges of both time and resources that primary care clinicians face on a daily basis. In the video below, she emphasizes that it is the duty of clinical guideline developers to guide new recommendations for implementing evidence-based interventions. She is a member of the ADA/EASD consensus report writing committee and explains that this is exactly what she and her co-authors did.
For more conversations with Dr Maruthur:
ADA, EASD 2022 Consensus Report from a Primary Care Perspective, with Nisa Maruthur, MD, MHS
Primary care would benefit from education on the use of SGLT-2 inhibitors, GLP-1 mimetics: Nisa Maruthur, MD, MHS
ADA/EASD calls for broad systemic change to address the impact of social health determinants